Nonocclusive bowel necrosis occurring in critically ill trauma patients receiving enteral nutrition manifests no reliable clinical signs for early detection

Citation
Rg. Marvin et al., Nonocclusive bowel necrosis occurring in critically ill trauma patients receiving enteral nutrition manifests no reliable clinical signs for early detection, AM J SURG, 179(1), 2000, pp. 7-12
Citations number
23
Categorie Soggetti
Surgery,"Medical Research Diagnosis & Treatment
Journal title
AMERICAN JOURNAL OF SURGERY
ISSN journal
00029610 → ACNP
Volume
179
Issue
1
Year of publication
2000
Pages
7 - 12
Database
ISI
SICI code
0002-9610(200001)179:1<7:NBNOIC>2.0.ZU;2-8
Abstract
BACKGROUND: Nonocclusive bowel necrosis (NOBN) has been associated with ear ly enteral nutrition (EN). The purpose of this study was to determine the i ncidence of this complication in our trauma intensive care unit population and to define a typical patient profile vulnerable to NOBN. METHODS: Thirteen cases of NOBN were identified among 4,311 patients (0.3%) over a 64-month period ending October 1998. Their charts were analyzed for a variety of clinical data, including prospective EN tolerance data in 4. RESULTS: Twelve (92%) patients were enterally fed prior to diagnosis for 10 +/- 8 days (range 3 to 21). Tachycardia (n = 12, 92%); fever/hypothermia, (0 = 12, 92%), and an abnormal white blood cell count (0 = 11, 85%) were co nsistently present. Abdominal distention was common but tended to be a late sign (0 = 12), Seven (56%) survived. In 4 patients with tolerance data, 3 reached the goal rate of feeds prior to diagnosis. Two became distended at >12 hours from diagnosis. Gastric tonometry demonstrated a decreased NgpHi (<7.30) after starting EN in all 3 in whom it was monitored. CONCLUSIONS: NOBN developed in 0.3% of our trauma patients. Onset occurs in the second week in high-acuity patients who have had a period of EN tolera nce. Clinical findings resemble bacterial sepsis with tachycardia, fever, a nd leukocytosis. Gastrointestinal specific signs are not consistent or occu r late. Thus, we could not identify an early, useful clinical indicator. Ga stric carbon dioxide tonometry may detect a vulnerable subgroup of patients . (C) 2000 by Excerpta Medica, Inc.